Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

575
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
575
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs01:15

Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs

396
Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
396
Bioequivalence of Drugs: Drugs with Multiple Indications01:09

Bioequivalence of Drugs: Drugs with Multiple Indications

219
The concept of therapeutic equivalence (TE) in drugs with multiple indications is complex. A generic drug may be therapeutically equivalent to a brand-name product for one specific indication, but this doesn't necessarily mean it's equivalent for all other indications. Evidence of TE in one patient group and bioequivalence shown in healthy volunteers can support—but not confirm—TE for other indications. However, definitive proof requires individual clinical studies for each...
219
Bioequivalence: Overview01:16

Bioequivalence: Overview

2.3K
Pharmaceutical equivalents, by definition, are drug products with the same active ingredient in the same quantities, encapsulated in identical dosage forms, and intended for the same administration routes. These pharmaceutical equivalents are deemed bioequivalent if the bioavailability of the active entity in the drug preparations is similar. Moreover, pharmaceutical equivalents demonstrating bioequivalence are also regarded as therapeutically equivalent. This means that when used as directed,...
2.3K
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

720
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
720
Bioequivalence Data: Statistical Interpretation01:16

Bioequivalence Data: Statistical Interpretation

345
The statistical interpretation of bioequivalence data is a significant aspect of pharmaceutical research. Bioequivalence refers to the absence of any significant difference in the rate and extent to which the active ingredient in pharmaceutical products becomes available at the site of drug action when administered at the same molar dose under similar conditions. This helps determine if different drug products have similar absorption rates, ensuring their interchangeability.Statistical...
345

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Influence of a COVID-19 Vaccine Mandate on Vaccination Rates in a University Setting.

American journal of public health·2024
Same author

Effects of Inclusion of Food Purchase Restrictions and Incentives in a Food Benefit Program on Diet Quality and Food Purchasing: Results From a Randomized Trial.

Journal of the Academy of Nutrition and Dietetics·2023
Same author

Author Correction: Randomization, design and analysis for interdependency in aging research: no person or mouse is an island.

Nature aging·2023
Same author

Randomization, design and analysis for interdependency in aging research: no person or mouse is an island.

Nature aging·2023
Same author

Examining perceived risk to bovine tuberculosis through factorial survey to inform policymaking for zoonotic diseases control and surveillance.

Preventive veterinary medicine·2022
Same author

Evaluation of the type I error rate when using parametric bootstrap analysis of a cluster randomized controlled trial with binary outcomes and a small number of clusters.

Computer methods and programs in biomedicine·2022
Same journal

Implementing a Novel Quality Improvement-Based Approach to Data Quality Monitoring and Enhancement in a Multipurpose Clinical Registry.

EGEMS (Washington, DC)·2019
Same journal

A Spatial Analysis of Health Disparities Associated with Antibiotic Resistant Infections in Children Living in Atlanta (2002-2010).

EGEMS (Washington, DC)·2019
Same journal

Predicting the Incidence of Pressure Ulcers in the Intensive Care Unit Using Machine Learning.

EGEMS (Washington, DC)·2019
Same journal

Cardiovascular Health Trends in Electronic Health Record Data (2012-2015): A Cross-Sectional Analysis of The Guideline Advantage™.

EGEMS (Washington, DC)·2019
Same journal

Understanding U.S. Health Systems: Using Mixed Methods to Unpack Organizational Complexity.

EGEMS (Washington, DC)·2019
Same journal

Improving a Secondary Use Health Data Warehouse: Proposing a Multi-Level Data Quality Framework.

EGEMS (Washington, DC)·2019
See all related articles

Related Experiment Video

Updated: Apr 15, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K

Effect identification in comparative effectiveness research.

J Michael Oakes1

  • 1University of Minnesota.

EGEMS (Washington, DC)
|April 8, 2015
PubMed
Summary
This summary is machine-generated.

Comparative Effectiveness Research (CER) using electronic medical records requires careful effect identification. Focusing on the right questions and methods, not just big data, is crucial for valid causal inferences in healthcare research.

More Related Videos

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Related Experiment Videos

Last Updated: Apr 15, 2026

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits
08:27

Applying an eMASS Customization Program as a Research Tool to Evaluate Consumer Benefits

Published on: September 27, 2019

7.3K
Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment
08:36

Author Spotlight: Evaluating the Adjuvant Efficacy and Safety of Angong Niuhuang Pill in Viral Encephalitis Treatment

Published on: April 19, 2024

1.4K
In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis
07:25

In Vitro Methods for Comparing Target Binding and CDC Induction Between Therapeutic Antibodies: Applications in Biosimilarity Analysis

Published on: May 4, 2017

18.3K

Area of Science:

  • Health Services Research
  • Biostatistics
  • Epidemiology

Background:

  • Electronic medical records (EMRs) provide vast data for Comparative Effectiveness Research (CER).
  • CER, alongside randomized controlled trials, can advance understanding of treatment outcomes across diverse populations and settings.
  • Current research culture's focus on correlations and p-values risks misinterpretation and flawed CER inferences.

Purpose of the Study:

  • To strengthen the inferential basis of CER.
  • To introduce the fundamental principles of effect identification for robust causal inference.
  • To highlight the importance of appropriate data and methods over sheer data volume.

Main Methods:

  • Explanation of effect identification as a process to discern empirically defensible causal effects.
  • Detailed discussion of three core requirements for effect identification: positivity, exchangeability, and consistency.
  • Inclusion of simple examples to illustrate these requirements.

Main Results:

  • Vast datasets from EMRs do not inherently guarantee superior or more useful research outcomes.
  • The validity of CER findings hinges on the careful application of effect identification principles.
  • Misinterpretation of results is a significant risk when inferential foundations are weak.

Conclusions:

  • Advances in CER depend on addressing the right research questions with appropriate data and methodologies.
  • Rigorous effect identification is essential for drawing valid causal conclusions from observational data.
  • The utility of big data in healthcare research is contingent upon methodological rigor and clear inferential goals.